Join the 200th Anniversary Celebration

Original Article

Long-Term Prognosis of Seizures with Onset in Childhood

Matti Sillanpää, M.D., Ph.D., Merja Jalava, M.D., Ph.D., Olli Kaleva, B.Sc., and Shlomo Shinnar, M.D., Ph.D.

N Engl J Med 1998; 338:1715-1722June 11, 1998

Abstract

Background

The long-term prognosis of seizures that begin in childhood is uncertain.

Methods

We prospectively studied 245 children from the catchment area of Turku University Hospital in Turku, Finland, who had active epilepsy diagnosed between 1961 and 1964. Sixty-eight patients (28 percent) had idiopathic seizures (presumed to have a genetic origin), 54 (22 percent) had cryptogenic seizures (occurring in otherwise normal persons with no clear cause), and 123 (50 percent) had remote symptomatic seizures (with no immediate cause but occurring in persons with a prior brain injury or a static encephalopathy).

Results

At the final follow-up in 1992, we had sufficient data on 220 patients (90 percent), 176 of whom were alive and 44 of whom had died; the remaining 25 had emigrated, could not be traced, or declined to participate. Thirty-nine patients who died were not free of seizures at the time of death, and 33 had remote symptomatic seizures. Among the surviving patients, 112 (64 percent) had been seizure-free for at least five years, including 83 (47 percent) who were not taking antiepileptic medications. The most important predictors of being seizure-free for at least five years were a rapid response to therapy (defined as a reduction in the frequency of seizures of 75 to 100 percent within three months of beginning treatment) and a diagnosis of idiopathic seizures. As compared with a matched control group, 99 patients with epilepsy but no other initial neurologic impairment were of similar socioeconomic status and had similar rates of passing an examination given after 12 years of school. Significantly more patients, however, had completed only six years of school (relative risk, 2.13), were unemployed (relative risk, 3.76), were not married (relative risk, 3.50), and did not have children (relative risk, 3.00).

Conclusions

Although the majority of patients with epilepsy in childhood are free of seizures by the time they become adults, they are at increased risk for social and educational problems. Patients whose epilepsy does not remit also have an increased risk of death.

Media in This Article

Figure 1Kaplan–Meier Estimates of the Cumulative Probability of a Five-Year Remission in a Cohort of 245 Finnish Patients with Onset of Epilepsy in Childhood.
Figure 2Kaplan–Meier Estimates of the Cumulative Probability of a Five-Year Remission without Antiepileptic Drugs in a Cohort of Finnish Patients with Onset of Epilepsy in Childhood, According to the Cause of Epilepsy.
Article

Most studies of the prognosis of epilepsy focus on short-term remission of seizures in patients with newly diagnosed epilepsy.1-5 Outcomes after long-term remission of seizures have been reported in well-designed retrospective studies in Minnesota, Sweden, and Japan.5-7 With a few notable exceptions,7,8 data on mortality have been obtained from reviews of medical records and death certificates or from studies of patients with refractory epilepsy.9-14 The long-term social, educational, and employment outcomes of people with childhood-onset epilepsy have not been a focus of study with the exception of a few reports of patients with refractory epilepsy who were seen in tertiary care centers.9,15 We report the long-term outcomes of a population-based cohort of 245 patients with epilepsy in childhood who were prospectively followed for several decades.

Methods

Patients

The study group included all children under 16 years of age who were living in the catchment area of University of Turku Hospital, Turku, Finland, at the end of 1964 who met the criteria for epilepsy (two or more unprovoked seizures).6,16-18 Patients were identified on the basis of hospital records and a review of the National Health Service records, a registry of all persons residing in Finland. Of the 245 patients identified, 223 (91 percent) were seen at University of Turku Hospital. The remaining 22 patients (9 percent) were seen at other hospitals and institutions in southern Finland. In Finland in the 1960s, all children with seizures were referred for evaluation. Ongoing surveillance of the national registry since that time has identified only three other patients who on review met the inclusion criteria and would have been included if identified at the proper time. Thus, the sample represents a population-based cohort of children under 16 years of age with epilepsy.

The 245 patients included 150 (61 percent) whose initial visit for evaluation of seizures occurred between January 1961 and December 1964 (incident cases). The remaining 95 (39 percent) were initially seen before 1961, but they were evaluated at least once during the study period of 1961 to 1964 and had had at least one seizure during the three years before that visit. All 245 were examined in 1972 by one pediatric neurologist,19 enrolled in a prospective, longitudinal study of outcomes, and followed for an additional 20 years. Follow-up included ongoing review of the medical records and a comprehensive reevaluation every five years. The final follow-up in 1992 consisted of a structured interview and a clinical examination. There were sufficient data for evaluation in the case of 176 patients who were alive in 1992 and 44 patients who had died (total, 90 percent). Of the remaining 25 (10 percent), 7 had emigrated, 10 could not be traced, and 8 declined to participate in the final follow-up.

Control Subjects

Of the 176 surviving patients with sufficient data for evaluation, 100 (57 percent) had uncomplicated epilepsy, which was defined as epilepsy without other initial neurologic impairment. For these 100 patients, a matched control group was selected from the nationwide population registry. We used stratified random sampling to choose four potential control subjects for each patient, matched for sex, age, and place of birth. Of the first 100 potential control subjects, only 5 declined to participate, and the appropriate 5 from the second 100 potential controls were then substituted. One control subject who had erroneously been identified as male was subsequently excluded. The remaining 99 pairs of patients and control subjects were all given detailed questionnaires and interviewed.

The study design was approved by the joint ethics committee of the Turku University Medical School and the University of Turku Hospital. Oral informed consent was obtained from all subjects.

Definitions

For this report, the types of seizures, epileptic syndromes, and the causes of seizures were reclassified according to the current classification schemes and the guidelines for epidemiologic research of the International League against Epilepsy.16-18 These guidelines16 classify seizures as remote symptomatic, cryptogenic, or idiopathic. Remote symptomatic seizures are those without an immediate cause in a patient with either an identifiable prior brain injury such as major head trauma, meningitis, or stroke or a static encephalopathy, such as mental retardation or cerebral palsy, that is known to be associated with an increased risk of seizures. Cryptogenic seizures are those occurring in otherwise normal persons with no clear cause. Until recently, cryptogenic seizures were also called idiopathic seizures. In the new classification, the term “idiopathic” is reserved for seizures occurring in patients with epilepsy with a presumed genetic origin, such as benign rolandic epilepsy and childhood absence epilepsy.16,18

A favorable early response to antiepileptic drugs was defined as a reduction of 75 to 100 percent in the frequency of seizures within three months after the initiation of treatment. Any patient who had been seizure-free for five years with or without medications was considered to be in remission.6 Patients were assessed to determine whether they had ever been in remission and whether they were in remission at the time of the last follow-up or death.

A patient with an IQ below 70 before the age of 18 years was considered to have mental retardation.20 Cerebral palsy was defined as a chronic, nonprogressive cerebral disorder in young children that resulted in impaired motor function.21 The results of a neurologic examination were classified as abnormal if definite abnormalities such as hemiparesis, bilateral paresis, ataxia, or cognitive impairment were present. The presence of clumsiness, learning disabilities, or other “soft” neurologic signs was not sufficient to classify a patient as having neurologic abnormalities.

Socioeconomic status was defined according to the criteria of the Central Statistical Office of Finland.22 The classification is based, according to United Nations recommendations, on various criteria such as occupation and employment status and includes seven categories. Since the number of subjects in some categories was very small, the upper three categories were combined and considered to represent higher socioeconomic status, corresponding to an income level of approximately $40,000 per year in the United States. The lower four categories were also combined and considered to represent lower socioeconomic status.

In the Finnish system of education, primary education is the equivalent of elementary-school education in the United States (kindergarten through sixth grade); a matriculation examination is taken after the completion of 12 years of schooling and is approximately equivalent to 1 year of college in the United States; and vocational training for specific occupations can begin after the ninth grade. The patients' levels of education were assessed with the use of these terms.

Statistical Analysis

We used statistical methods that take into account the time-dependent nature of the data23-26 using BMDP software.27 The product-limit method was used to calculate the risk of death and of remission at various times after the onset of the seizure disorder.23,26 Standard errors and 95 percent confidence intervals for the point estimates were calculated with a modification of Greenwood's formula.24,27 The results are displayed by means of Kaplan–Meier curves.23,24 Univariate and multivariable analyses were performed with the Cox proportional-hazards model.24-27 The rate ratio was used as a measure of the magnitude of the association between a variable and the risk of the measured outcome (death, remission, or remission in the absence of medications).24-27 For the comparison of social outcomes between subjects and controls, relative risks were used.26,27 The 95 percent confidence intervals were calculated from the logistic-regression models with a formula based on the normal approximation.26,27 In addition, Pearson's chi-square test, with Yates' correction when appropriate, and Fisher's exact test (two-tailed) were used. A P value of less than 0.05 was considered to indicate statistical significance. All P values are two-tailed.

Results

Characteristics of the Subjects

The cohort included 134 male patients (55 percent) and 111 female patients (45 percent). The mean age at onset of epilepsy was 4.3 years (median, 3.0). At the time of the last follow-up, in 1992, the mean age was 32.5 years in the entire cohort and 35.6 years in the group of 176 surviving patients for whom data were available. During the period from January 1961 to December 1964, a total of 108,019 children under the age of 16 resided in the catchment area of University of Turku Hospital. The estimated annual incidence of epilepsy in this population was 0.35 per 1000 (95 percent confidence interval, 0.24 to 0.49), and the estimated prevalence of active epilepsy was 2.3 per 1000 (95 percent confidence interval, 1.46 to 3.45). The seizures were classified as idiopathic in 68 patients (28 percent), cryptogenic in 54 patients (22 percent), and remote symptomatic in 123 patients (50 percent). There were no significant differences between the 150 patients with incident cases and the other 95 patients with respect to cause or type of seizures and epilepsy syndrome.

Mortality

Data on mortality are summarized in Table 1Table 1Rates and Causes of Death among a Cohort of Finnish Patients with Onset of Epilepsy in Childhood.. There were 44 documented deaths (18 percent), yielding a mortality rate of 6.23 per 1000 person-years (95 percent confidence interval, 5.72 to 6.71). The overall probability of survival was 0.94 (95 percent confidence interval, 0.91 to 0.97) 10 years after the onset of seizures, 0.88 (95 percent confidence interval, 0.84 to 0.92) 20 years after onset, and 0.75 (95 percent confidence interval, 0.64 to 0.86) 40 years after onset. The probability of survival as a function of age was 0.96 at 10 years of age (95 percent confidence interval, 0.94 to 0.99), 0.89 at 20 years of age (95 percent confidence interval, 0.85 to 0.93), and 0.80 at 40 years of age (95 percent confidence interval, 0.76 to 0.86).

The cause of the seizures strongly influenced mortality. The probability of survival to the age of 40 was 0.87 among patients with idiopathic seizures (95 percent confidence interval, 0.77 to 0.96), 0.93 among those with cryptogenic seizures (95 percent confidence interval, 0.86 to 0.99), and 0.73 among those with remote symptomatic seizures (95 percent confidence interval, 0.65 to 0.81; P<0.001 for the comparison with the other two groups). The mortality rate was also somewhat lower among patients with incident cases (4.76 per 1000 person-years; 95 percent confidence interval, 4.38 to 5.25) than among the other 95 patients (8.37 per 1000 person-years; 95 percent confidence interval, 7.84 to 8.99); the relative risk of death among those with incident cases was 0.53 (95 percent confidence interval, 0.31 to 0.90; P=0.03). Thirty-nine of the 44 patients who died (89 percent) were not in remission at the time of death (relative risk of death among those not in remission as compared with those in remission, 9.26; 95 percent confidence interval, 3.78 to 22.70; P<0.001). Death was definitely or probably related to a seizure in 20 cases. There were three cases of sudden unexplained death in patients with idiopathic epilepsy (at the ages of 13, 32, and 36) who were not in remission.

Remission

The data on remission are shown in Figure 1Figure 1Kaplan–Meier Estimates of the Cumulative Probability of a Five-Year Remission in a Cohort of 245 Finnish Patients with Onset of Epilepsy in Childhood.. The majority of patients who were alive at the time of the last follow-up had had a remission or were still in remission. Of 83 surviving patients who were in remission without medication at the last follow-up, 58 (70 percent) had been seizure-free for more than 20 years. Of the 176 surviving patients with sufficient data for analysis, 143 (81 percent) were in remission at some point. Of these 143, 67 (47 percent) subsequently relapsed, 49 while receiving antiepileptic medications. Thirty-six of the 67 who relapsed (54 percent) were in remission at the time of the last follow-up.

Multivariable analysis showed that the cause of the seizures, the response to anticonvulsant therapy, the initial frequency of seizures, and the type of seizures were all associated with a surviving patient's probability of being in remission at the time of the last follow-up (Table 2Table 2Multivariable Analysis of a Surviving Patient's Probability of Being in Remission at the Time of the Last Follow-up.). The results were similar when the analysis was limited to patients with incident cases (Table 2). Patients with remote symptomatic seizures were significantly less likely to have a remission (Figure 2Figure 2Kaplan–Meier Estimates of the Cumulative Probability of a Five-Year Remission without Antiepileptic Drugs in a Cohort of Finnish Patients with Onset of Epilepsy in Childhood, According to the Cause of Epilepsy.) or to be in remission at the time of the last follow-up, particularly in the absence of medications (Table 2), than patients with idiopathic or cryptogenic seizures (P<0.001 for the comparison among groups). Patients with remote symptomatic epilepsy were also more likely to continue taking medication despite being in remission. An early response to drug therapy was the single best predictor of remission both in the overall cohort and in the three subgroups classified according to the cause of seizures (Table 2). An initial seizure frequency of less than once a month was also associated with a more favorable prognosis, but the number of seizures recorded before drug therapy was initiated was not related to the probability of remission. The type of seizure was also associated with the probability of remission (Table 2).

Social and Educational Outcomes

The relative risks of various social and educational outcomes among 99 patients with uncomplicated epilepsy, as compared with control subjects matched for age, sex, and place of birth, are shown in Table 3Table 3Relative Risks of Various Social and Educational Outcomes among 99 Patients with Uncomplicated Epilepsy as Compared with Control Subjects Matched for Age, Sex, and Place of Birth.. The patients with uncomplicated epilepsy had significantly worse outcomes for all social and educational variables except the one related to passing the matriculation examination. The results were similar when the analysis was limited to patients with incident cases. All children with uncomplicated epilepsy had at least a primary education. However, the patients were less likely than the control subjects to have continued their education. Despite these differences in the level of education, the socioeconomic status of the patients and the controls was similar. Not surprisingly, the 76 patients with epilepsy and other disabilities had poorer outcomes on each of these measures than the 99 patients with uncomplicated epilepsy (data not shown).

Similar proportions of patients with uncomplicated epilepsy in remission without medication at the time of the last follow-up and control subjects were of higher socioeconomic status and held a driver's license (Table 3). However, the patients were less likely to be married or living with someone or have children and had a marginally lower probability of being employed. The findings were similar when the analysis was limited to patients with incident cases or to those with idiopathic epilepsy. Of 66 patients with uncomplicated epilepsy in remission without medication at the time of the last follow-up, 47 (71 percent) had been in remission since the age of 20. Thus, adverse social effects persisted even in patients who entered adult life free of seizures and seizure medication.

There were too few patients with uncomplicated epilepsy in remission who were taking medication (nine) for a comparison with those in remission without medication. However, 4 patients (44 percent) who were in remission with medication had a driver's license, as compared with 52 patients (79 percent) in remission without medication (P=0.4) and 88 control subjects (89 percent, P=0.003). In Finland, patients with well-controlled epilepsy may drive.

Discussion

We assessed the long-term outcome of a population-based cohort with epilepsy of childhood onset that was prospectively followed for many years by a single pediatric neurologist. The strengths of this study are the long-term follow-up with a high rate of retention of subjects, the availability of detailed information permitting accurate classification of the type of seizures, the epilepsy syndrome, and the cause of seizures, as well as an assessment of social and seizure-related outcomes.

The incidence and prevalence of epilepsy and seizures are consistent with those reported in other population-based studies.9,28-30 The proportion of patients with idiopathic seizures is also similar to that in other series.31 The higher proportion of patients with remote symptomatic epilepsy in our cohort than in other studies is due to the extensive analysis of the patients, which led to a reclassification of the cause in numerous patients and thus reduced the proportion of patients with cryptogenic epilepsy. Many patients initially considered to have cryptogenic epilepsy are subsequently found to have remote symptomatic epilepsy.32

Mortality

Patients with epilepsy have an increased risk of death, including sudden death.7-14 The high death rate in our cohort may be partly accounted for by the higher proportion of patients with remote symptomatic epilepsy and by the fact that we counted all deaths in the cohort whether or not they were attributable to the seizure disorder. The lower mortality rate among our patients with incident cases was not accompanied by differences in other outcome measures in the surviving patients. In prior studies of children with seizures, the children were rarely followed into adulthood, when most of the deaths occur.5,7-9 The mortality rates in this cohort were similar to those reported in adults with refractory epilepsy, many of whom first began to have seizures in childhood.13,14

Remission

The data on overall remission are consistent with those reported in Rochester, Minnesota,6 and the United Kingdom.33 As in other studies, the cause of seizures was consistently associated with the probability of remission.5-7,33 The variable most strongly associated with remission was an early response to drug therapy. Other studies have reported that patients who have a response within the first year of therapy have a better prognosis.1,2,6 These findings suggest that in selected situations, children and adolescents with persistent seizures may be candidates for surgery34 after two years of appropriate medical therapy. However, although those with an early response did well, many of the children who did not have early responses eventually entered remission, a finding in agreement with a recent report on the prognosis of refractory childhood epilepsy.35 These data on the early response to treatment are from an era that preceded the introduction of carbamazepine, valproate, and other, newer medications.36 Although we believe that an early response to treatment is still valid as a predictor of favorable outcome, a higher proportion of patients without an early response than in our cohort may eventually enter remission with the use of these newer medications. The rate of remission without medication is less likely to be affected by the availability of new drugs, since it reflects the underlying course of the disorder.37

Social and Educational Outcomes

The occurrence of seizures in childhood appears to have a long-term adverse impact on a patient's level of education and likelihood of employment, marriage, and having children. These adverse effects were found even in patients with idiopathic epilepsy in remission without medication, a group that would be expected to have the most favorable outcomes. This difference is not due simply to discrimination, since similar proportions of patients and control subjects had passed the matriculation examination and had higher socioeconomic status. Few data on educational outcomes in unselected groups of patients are available for purposes of comparison.38 Studies of patients attending seizure clinics have reported academic underachievement in relation to IQ39 and a higher proportion of unfavorable educational outcomes than in the general population.15,40-42

Several studies of adults with active epilepsy have indicated they have lower rates of employment than similar control subjects from the general population.15,41,43,44 The differences were attributed to discrimination and to problems related to the active seizure disorder. Studies of patients who had refractory epilepsy in childhood also reported poor long-term employment outcomes even if the patients later became seizure-free.15 Our study demonstrates that even the mildest forms of childhood epilepsy can have a lifelong effect on employment status.

As compared with the general population, adults who had refractory temporal-lobe epilepsy as adolescents15 and adults with active epilepsy who were attending a seizure clinic41 were less likely to be married. Decreased fertility has also been described in patients with refractory epilepsy15,45 and in men and women with active epilepsy.45 A younger age at onset of epilepsy was associated with a decreased likelihood of having children, even after adjustment for the lower marriage rates.45 The current data raise concern about the long-term adverse effects on marriage and fertility associated with the occurrence of even relatively mild seizure disorders in childhood. It is unlikely that more aggressive medical treatment would have altered the clinical course in the majority of the patients that we studied, since most had mild, self-limited epilepsy that responded readily to therapy.

Conclusions

The majority of patients with epilepsy that begins in childhood will become free of seizures by adulthood. Those who do not enter remission have an increased risk of death. Although patients with uncomplicated epilepsy have a favorable long-term medical prognosis, they are more likely to have lower levels of education and employment than the general population and less likely to marry or have children, even if they have been seizure-free without medication for many years. Future interventions will need to focus on the social aspects as well as the medical aspects of treating seizures.

Supported in part by grants from the Finnish Epilepsy Research Foundation and Turun Sanomat Group Printing House (to Dr. Jalava) and by a grant (NS26151) from the National Institute of Neurological Disorders and Stroke (to Dr. Shinnar).

Source Information

From the Departments of Pediatric Neurology (M.S., M.J.) and Biostatistics (O.K.), University of Turku, Turku, Finland; and the Departments of Neurology and Pediatrics and the Comprehensive Epilepsy Management Center, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, N.Y. (S.S.).

Address reprint requests to Dr. Sillanpää at the Department of Child Neurology, University of Turku Hospital TYKS, 20520 Turku, Finland.

References

References

  1. 1

    Beghi E, Tognoni G. Prognosis of epilepsy in newly referred patients: a multicenter prospective study. Epilepsia 1988;29:236-243
    CrossRef | Web of Science | Medline

  2. 2

    Elwes RDC, Johnson AL, Shorvon SD, Reynolds EH. The prognosis for seizure control in newly diagnosed epilepsy. N Engl J Med 1984;311:944-947
    Full Text | Web of Science | Medline

  3. 3

    Camfield C, Camfield P, Gordon K, Smith B, Dooley J. Outcome of childhood epilepsy: a population-based study with a simple predictive scoring system for those treated with medication. J Pediatr 1993;122:861-868
    CrossRef | Web of Science | Medline

  4. 4

    Sofijanov NG. Clinical evolution and prognosis of childhood epilepsies. Epilepsia 1982;23:61-69
    CrossRef | Web of Science | Medline

  5. 5

    Berg AT, Hauser WA, Shinnar S. The prognosis of childhood-onset epilepsy. In: Shinnar S, Amir N, Branski D, eds. Childhood seizures. Basel, Switzerland: S. Karger, 1995:93-9.

  6. 6

    Annegers JF, Hauser WA, Elveback LR. Remission of seizures and relapse in patients with epilepsy. Epilepsia 1979;20:729-737
    CrossRef | Web of Science | Medline

  7. 7

    Brorson LO, Wranne L. Long-term prognosis in childhood epilepsy: survival and seizure prognosis. Epilepsia 1987;28:324-330
    CrossRef | Web of Science | Medline

  8. 8

    Hauser WA, Annegers JF, Elveback LR. Mortality in patients with epilepsy. Epilepsia 1980;21:339-412
    CrossRef | Web of Science

  9. 9

    Hauser WA, Hesdorffer DC. Epilepsy: frequency, causes and consequences. New York: Demos, 1990.

  10. 10

    Lathers CM, Schraeder PL, eds. Epilepsy and sudden death. New York: Marcel Dekker, 1990.

  11. 11

    Leestma JE, Walczak T, Hughes JR, Kalelkar MB, Teas SS. A prospective study on sudden unexpected death in epilepsy. Ann Neurol 1989;26:195-203
    CrossRef | Web of Science | Medline

  12. 12

    Tennis P, Cole TB, Annegers JF, Leestma JE, McNutt M, Rajput A. Cohort study of incidence of sudden unexplained death in persons with seizure disorder treated with antiepileptic drugs in Saskatchewan, Canada. Epilepsia 1995;36:29-36
    CrossRef | Web of Science | Medline

  13. 13

    Nashef L, Fish DR, Garner S, Sander JW, Shorvon SD. Sudden death in epilepsy: a study of incidence in a young cohort with epilepsy and learning difficulty. Epilepsia 1995;36:1187-1194
    CrossRef | Web of Science | Medline

  14. 14

    Derby LE, Tennis P, Jick H. Sudden unexplained death among subjects with refractory epilepsy. Epilepsia 1996;37:931-935
    CrossRef | Web of Science | Medline

  15. 15

    Ounsted C, Lindsay J, Richards P. Temporal lobe epilepsy 1948–1986: a biographical study. No. 103 of Clinics in developmental medicine. London: Mac Keith Press, 1987.

  16. 16

    Commission on Epidemiology and Prognosis, International League against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia 1993;34:592-596
    CrossRef | Web of Science | Medline

  17. 17

    Commission on Classification and Terminology of the International League against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501
    CrossRef | Web of Science | Medline

  18. 18

    Commission on Classification and Terminology of the International League against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399
    CrossRef | Web of Science | Medline

  19. 19

    Sillanpaa M. Medico-social prognosis of children with epilepsy: epidemiological study and analysis of 245 patients. Acta Paediatr Scand Suppl 1973;237:1-104

  20. 20

    International classification of impairments, disabilities, and handicaps: a manual of classification relating to consequences of disease. Geneva: World Health Organization, 1980.

  21. 21

    Bax MCO. Terminology and classification of cerebral palsy. Dev Med Child Neurol 1964;6:295-297
    CrossRef | Medline

  22. 22

    Classification of socio-economic groups. Helsinki, Finland: Central Statistical Office of Finland, 1989. (In Finnish.)

  23. 23

    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
    CrossRef | Web of Science

  24. 24

    Elandt-Johnson RC, Johnson NL. Survival models and data analysis. New York: John Wiley, 1980:150-80.

  25. 25

    Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-220

  26. 26

    Kelsey JL, Thompson WD, Evans AS. Methods in observational epidemiology. New York: Oxford University Press, 1986.

  27. 27

    Dixon W. BMDP statistical software. Berkeley: University of California Press, 1990.

  28. 28

    Berg AT. The epidemiology of seizures and epilepsy in children. In: Shinnar S, Amir N, Branski D, eds. Childhood seizures. Basel, Switzerland: S. Karger, 1995:1-10.

  29. 29

    Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993;34:453-468
    CrossRef | Web of Science | Medline

  30. 30

    Camfield CS, Camfield PR, Gordon K, Wirrell E, Dooley J. Incidence of epilepsy in childhood and adolescence: a population-based study in Nova Scotia from 1977 to 1985. Epilepsia 1996;37:19-23
    CrossRef | Web of Science | Medline

  31. 31

    Berg AT, Levy SR, Testa FM, Smith-Rapaport S, Shinnar S. Newly diagnosed epilepsy in children: the ILAE classification system applied in a community-based cohort. Epilepsia 1995;36:Suppl 4:29-29 abstract.
    CrossRef | Web of Science | Medline

  32. 32

    Berg AT, Levy SR, Novotny EJ, Shinnar S. Predictors of intractable epilepsy in childhood: a case-control study. Epilepsia 1996;37:24-30
    CrossRef | Web of Science | Medline

  33. 33

    Cockerell OC, Johnson AL, Sander JWAS, Hart YM, Shorvon SD. Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet 1995;346:140-144
    CrossRef | Web of Science | Medline

  34. 34

    Engel J Jr. Surgery for seizures. N Engl J Med 1996;334:647-652
    Full Text | Web of Science | Medline

  35. 35

    Huttenlocher PR, Hapke RJ. A follow-up study of intractable seizures in childhood. Ann Neurol 1990;28:699-705
    CrossRef | Web of Science | Medline

  36. 36

    Dichter MA, Brodie MJ. New antiepileptic drugs. N Engl J Med 1996;334:1583-1590
    Full Text | Web of Science | Medline

  37. 37

    Shinnar S, Berg AT. Does antiepileptic drug therapy prevent the development of “chronic“ epilepsy? Epilepsia 1996;37:701-708
    CrossRef | Web of Science | Medline

  38. 38

    Camfield C, Camfield P, Smith B, Gordon K, Dooley J. Biologic factors as predictors of social outcome of epilepsy in intellectually normal children: a population-based study. J Pediatr 1993;122:869-873
    CrossRef | Web of Science | Medline

  39. 39

    Mitchell WG, Chavez JM, Lee H, Guzman BL. Academic underachievement in children with epilepsy. J Child Neurol 1991;6:65-72
    CrossRef | Web of Science | Medline

  40. 40

    Westbrook LE, Silver EJ, Coupey SM, Shinnar S. Social characteristics of adolescents with idiopathic epilepsy: a comparison to chronically ill and non chronically ill peers. J Epilepsy 1991;4:87-94
    CrossRef

  41. 41

    Callaghan N, Crowley M, Goggin T. Epilepsy and employment, marital, education and social status. Ir Med J 1992;85:17-19
    Medline

  42. 42

    Carlton-Ford S, Miller R, Brown M, Nealeigh N, Jennings P. Epilepsy and children's social and psychological adjustment. J Health Soc Behav 1995;36:285-301
    CrossRef | Web of Science | Medline

  43. 43

    Olsson I, Campenhausen G. Social adjustment in young adults with absence epilepsies. Epilepsia 1993;34:846-851
    CrossRef | Web of Science | Medline

  44. 44

    Jacoby A, Baker GA, Steen N, Potts P, Chadwick DW. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia 1996;37:148-161
    CrossRef | Web of Science | Medline

  45. 45

    Schupf N, Ottman R. Likelihood of pregnancy in individuals with idiopathic/cryptogenic epilepsy: social and biologic influences. Epilepsia 1994;35:750-756
    CrossRef | Web of Science | Medline

Citing Articles (209)

Citing Articles

  1. 1

    Ksenija Gebauer-Bukurov, Ksenija Bozic, Slobodan Sekulic. (2012) Clinical characteristics and use of antiepileptic drugs among adolescents with uncomplicated epilepsy at a referral center in Novi Sad, Serbia. Acta Neurologica Belgica
    CrossRef

  2. 2

    Vadim Beletsky, Seyed M. Mirsattari. (2012) Epilepsy, Mental Health Disorder, or Both?. Epilepsy Research and Treatment 2012, 1-13
    CrossRef

  3. 3

    Christine B. Baca, Barbara G. Vickrey, Stefanie D. Vassar, Anne T. Berg. (2011) Seizure recency and quality of life in adolescents with childhood-onset epilepsy. Epilepsy & Behavior
    CrossRef

  4. 4

    Colin Reilly, Brian G.R. Neville. (2011) Academic achievement in children with epilepsy: A review. Epilepsy Research 97:1-2, 112-123
    CrossRef

  5. 5

    COLIN REILLY, REBECCA BALLANTINE. (2011) Epilepsy in school-aged children: more than just seizures?. Support for Learning 26:4, 144-151
    CrossRef

  6. 6

    Mirela Boscariol, Catarina Abraão Guimarães, Simone R de Vasconcellos Hage, Vera Lucia Garcia, Kátia M R Schmutzler, Fernando Cendes, Marilisa Mantovani Guerreiro. (2011) Auditory processing disorder in patients with language-learning impairment and correlation with malformation of cortical development. Brain and Development 33:10, 824-831
    CrossRef

  7. 7

    Anne T. Berg, Francine M. Testa, Susan R. Levy. (2011) Complete remission in nonsyndromic childhood-onset epilepsy. Annals of Neurology 70:4, 566-573
    CrossRef

  8. 8

    Ada Geerts, Oebele Brouwer, Cees van Donselaar, Hans Stroink, Boudewijn Peters, Els Peeters, Willem F. Arts. (2011) Health perception and socioeconomic status following childhood-onset epilepsy: The Dutch study of epilepsy in childhood. Epilepsiano-no
    CrossRef

  9. 9

    Roos Rodenburg, Janelle L. Wagner, Joan K. Austin, Michael Kerr, David W. Dunn. (2011) Psychosocial issues for children with epilepsy. Epilepsy & Behavior 22:1, 47-54
    CrossRef

  10. 10

    Karen L. Skjei, Dennis J. Dlugos. (2011) The Evaluation of Treatment-Resistant Epilepsy. Seminars in Pediatric Neurology 18:3, 150-170
    CrossRef

  11. 11

    Sarah A. Kelley, Adam L. Hartman. (2011) Metabolic Treatments for Intractable Epilepsy. Seminars in Pediatric Neurology 18:3, 179-185
    CrossRef

  12. 12

    K. Å. Alfstad, J. Clench-Aas, B. Van Roy, P. Mowinckel, L. Gjerstad, M. I. Lossius. (2011) Gender differences in risk-taking behaviour in youth with epilepsy: a Norwegian population-based study. Acta Neurologica Scandinavica 124, 12-17
    CrossRef

  13. 13

    Richard F. M. Chin, Phillippa M. Cumberland, Suresh S. Pujar, Catherine Peckham, Euan M. Ross, Rod C. Scott. (2011) Outcomes of childhood epilepsy at age 33 years: A population-based birth-cohort study. Epilepsia 52:8, 1513-1521
    CrossRef

  14. 14

    Georgia D. Montouris. (2011) Rational approach to treatment options for Lennox-Gastaut syndrome. Epilepsia 52, 10-20
    CrossRef

  15. 15

    Peter R. Camfield. (2011) Definition and natural history of Lennox-Gastaut syndrome. Epilepsia 52, 3-9
    CrossRef

  16. 16

    John O. Elliott, Christine Charyton, James W. McAuley, Bassel F. Shneker. (2011) The impact of marital status on epilepsy-related health concerns. Epilepsy Research 95:3, 200-206
    CrossRef

  17. 17

    Pysse Jonsson, Orvar Eeg-Olofsson. (2011) 10-Year outcome of childhood epilepsy in well-functioning children and adolescents. European Journal of Paediatric Neurology 15:4, 331-337
    CrossRef

  18. 18

    Lorie D. Hamiwka, Lorraine A. Hamiwka, Elisabeth M.S. Sherman, Elaine Wirrell. (2011) Social skills in children with epilepsy: How do they compare to healthy and chronic disease controls?. Epilepsy & Behavior 21:3, 238-241
    CrossRef

  19. 19

    Kristin Å. Alfstad, Jocelyne Clench-Aas, Betty Van Roy, Petter Mowinckel, Leif Gjerstad, Morten I. Lossius. (2011) Psychiatric symptoms in Norwegian children with epilepsy aged 8-13 years: Effects of age and gender?. Epilepsia 52:7, 1231-1238
    CrossRef

  20. 20

    A. Marinas, E. Elices, A. Gil-Nagel, J. Salas-Puig, J.C. Sánchez, M. Carreño, V. Villanueva, J. Rosendo, J. Porcel, J.M. Serratosa. (2011) Socio-occupational and employment profile of patients with epilepsy. Epilepsy & Behavior 21:3, 223-227
    CrossRef

  21. 21

    Matti Sillanpää, Dieter Schmidt. (2011) Predicting antiepileptic drug response in children with epilepsy. Expert Review of Neurotherapeutics 11:6, 877-886
    CrossRef

  22. 22

    Marianne C. Cunnington, David J. Webb, Michael C. Irizarry, Ranjani Manjunath. (2011) Risk factors for antiepileptic drug regimen change in patients with newly diagnosed epilepsy. Epilepsy & Behavior 21:2, 168-172
    CrossRef

  23. 23

    Ruth Ackers, Frank M.C. Besag, Elaine Hughes, Waney Squier, Macey L. Murray, Ian C.K. Wong. (2011) Mortality Rates and Causes of Death in Children with Epilepsy Prescribed Antiepileptic Drugs. Drug Safety 34:5, 403-413
    CrossRef

  24. 24

    Lorie Hamiwka, Sophia Macrodimitris, Jose F. Tellez-Zenteno, Amy Metcalfe, Samuel Wiebe, Churl-Su Kwon, Nathalie Jetté, . (2011) Social outcomes after temporal or extratemporal epilepsy surgery: A systematic review. Epilepsia 52:5, 870-879
    CrossRef

  25. 25

    Matti Sillanpää, Sakari Suominen, Päivi Rautava, Minna Aromaa. (2011) Academic and social success in adolescents with previous febrile seizures. Seizure 20:4, 326-330
    CrossRef

  26. 26

    Hilde M. H. Braakman, Maarten J. Vaessen, Paul A. M. Hofman, Mariette H. J. A. Debeij-van Hall, Walter H. Backes, Johan S. H. Vles, Albert P. Aldenkamp. (2011) Cognitive and behavioral complications of frontal lobe epilepsy in children: A review of the literature. Epilepsia 52:5, 849-856
    CrossRef

  27. 27

    Elaine C. Wirrell, Brandon R. Grossardt, Elson L. So, Katherine C. Nickels. (2011) A population-based study of long-term outcomes of cryptogenic focal epilepsy in childhood: Cryptogenic epilepsy is probably not symptomatic epilepsy. Epilepsia 52:4, 738-745
    CrossRef

  28. 28

    John O. Elliott, Christine Charyton, Peter Sprangers, Bo Lu, J. Layne Moore. (2011) The impact of marriage and social support on persons with active epilepsy. Epilepsy & Behavior 20:3, 533-538
    CrossRef

  29. 29

    Brian Callaghan, Malka Schlesinger, William Rodemer, John Pollard, Dale Hesdorffer, W. Allen Hauser, Jacqueline French. (2011) Remission and relapse in a drug-resistant epilepsy population followed prospectively. Epilepsia 52:3, 619-626
    CrossRef

  30. 30

    N. Swiderska, J. Gondwe, J. Joseph, J. Gibbs. (2011) The prevalence and management of epilepsy in secondary school pupils with and without special educational needs. Child: Care, Health and Development 37:1, 96-102
    CrossRef

  31. 31

    Seye Abimbola, Alexandra L.C. Martiniuk, Maree L. Hackett, Craig S. Anderson. (2011) The Influence of Design and Definition on the Proportion of General Epilepsy Cohorts with Remission and Intractability. Neuroepidemiology 36:3, 204-212
    CrossRef

  32. 32

    Sillanpää, Matti, Shinnar, Shlomo, . (2010) Long-Term Mortality in Childhood-Onset Epilepsy. New England Journal of Medicine 363:26, 2522-2529
    Full Text

  33. 33

    Gilbert Munyoki, Tansy Edwards, Steve White, Thomas Kwasa, Eddie Chengo, Gilbert Kokwaro, Victor Mung’ala Odera, Josemir W Sander, Brian G. Neville, Charles R Newton. (2010) Clinical and neurophysiologic features of active convulsive epilepsy in rural Kenya: A population-based study. Epilepsia 51:12, 2370-2376
    CrossRef

  34. 34

    Yoshimi Sogawa, David Masur, Christine O’Dell, Solomon L. Moshe, Shlomo Shinnar. (2010) Cognitive outcomes in children who present with a first unprovoked seizure. Epilepsia 51:12, 2432-2439
    CrossRef

  35. 35

    2010. Further Reading. , 378-407.
    CrossRef

  36. 36

    Maria Hnojciková, Katherine C. Nickels, Nicholas M. Wetjen, Jeffrey R. Buchhalter, Corey Raffel, Elaine C. Wirrell. (2010) EEG and Neuroimaging Studies in Young Children Having Epilepsy Surgery. Pediatric Neurology 43:5, 335-340
    CrossRef

  37. 37

    Yanghua Tian, Bin Dong, Ji Ma, Shanshan Zhou, Nong Zhou, Kai Wang. (2010) Attention networks in children with idiopathic generalized epilepsy. Epilepsy & Behavior 19:3, 513-517
    CrossRef

  38. 38

    Bláthnaid McCoy, Selim R Benbadis. (2010) Approach to refractory childhood seizures. Therapy 7:5, 497-506
    CrossRef

  39. 39

    Vera C. Terra, Fulvio A. Scorza, Esper A. Cavalheiro, Lauro Wichert-Ana, Kylvia G. F. D. Pinto, Helio R. Machado, Américo C. Sakamoto. (2010) Pediatric epilepsy surgery and sudden unexpected death epilepsy: the contribution of a Brazilian epilepsy surgery program. Child's Nervous System 26:8, 1075-1079
    CrossRef

  40. 40

    Asla Pitkänen. (2010) Therapeutic approaches to epileptogenesis-Hope on the horizon. Epilepsia 51, 2-17
    CrossRef

  41. 41

    Jana E. Jones, Prabha Siddarth, Suresh Gurbani, W. Donald Shields, Rochelle Caplan. (2010) Cognition, academic achievement, language, and psychopathology in pediatric chronic epilepsy: Short-term outcomes. Epilepsy & Behavior 18:3, 211-217
    CrossRef

  42. 42

    Ada Geerts, Willem F. Arts, Hans Stroink, Els Peeters, Oebele Brouwer, Boudewijn Peters, Laura Laan, Cees Van Donselaar. (2010) Course and outcome of childhood epilepsy: A 15-year follow-up of the Dutch Study of Epilepsy in Childhood. Epilepsia 51:7, 1189-1197
    CrossRef

  43. 43

    Matti Sillanpää, Dieter Schmidt. (2010) Long-term employment of adults with childhood-onset epilepsy: A prospective population-based study. Epilepsia 51:6, 1053-1060
    CrossRef

  44. 44

    Ingrid Tuxhorn, Elaine Wyllie. (2010) Should cognitive assessment be performed on children newly diagnosed with epilepsy?. Expert Review of Neurotherapeutics 10:6, 839-842
    CrossRef

  45. 45

    Sebahattin Vurucu, Mehmet Saldir, Bulent Unay, Ridvan Akin. (2010) Determination of risk factors associated with seizure relapse after antiepileptic drug withdrawal. Central European Journal of Medicine 5:2, 251-256
    CrossRef

  46. 46

    David W. Loring, Bruce P. Hermann, Morris J. Cohen. (2010) Neuropsychological Advocacy and Epilepsy. The Clinical Neuropsychologist 24:3, 417-428
    CrossRef

  47. 47

    Kati Rantanen, Pirkko Nieminen, Kai Eriksson. (2010) Neurocognitive functioning of preschool children with uncomplicated epilepsy. Journal of Neuropsychology 4:1, 71-87
    CrossRef

  48. 48

    Alessandra Del Felice, Ettore Beghi, Giovanni Boero, Angela La Neve, Graziella Bogliun, Alessia De Palo, Luigi M. Specchio. (2010) Early versus late remission in a cohort of patients with newly diagnosed epilepsy. Epilepsia 51:1, 37-42
    CrossRef

  49. 49

    Rochelle Caplan, Prabha Siddarth, Pamela Vona, Lesley Stahl, Caroline Bailey, Suresh Gurbani, Raman Sankar, W. Donald Shields. (2009) Language in pediatric epilepsy. Epilepsia 50:11, 2397-2407
    CrossRef

  50. 50

    Matti Sillanpää, Dieter Schmidt. (2009) Delayed time to first remission identifies poor long-term drug response of childhood-onset epilepsy: A prospective population-based study. Epilepsy & Behavior 16:3, 507-511
    CrossRef

  51. 51

    James R. White, Ilo E. Leppik, Jeanne L. Beattie, Thaddeus S. Walczak, Teresa A. Tran, John O. Rarick, Paul Vaher. (2009) Long-term use of felbamate: Clinical outcomes and effect of age and concomitant antiepileptic drug use on its clearance. Epilepsia 50:11, 2390-2396
    CrossRef

  52. 52

    Hyunmi Choi, Richard Carlino, Gary Heiman, W. Allen Hauser, Frank G. Gilliam. (2009) Evaluation of duration of epilepsy prior to temporal lobe epilepsy surgery during the past two decades. Epilepsy Research 86:2-3, 224-227
    CrossRef

  53. 53

    Gregory L. Holmes. (2009) The 2008 Judith Hoyer Lecture: Epilepsy in children: Listening to mothers. Epilepsy & Behavior 16:2, 193-202
    CrossRef

  54. 54

    Cigdem I. Akman, Maria A. Montenegro, Susan Jacob, Karen Eck, Danielle McBrian, Claudia A. Chiriboga, Marc C. Patterson. (2009) Subclinical seizures in children diagnosed with localization-related epilepsy: Clinical and EEG characteristics. Epilepsy & Behavior 16:1, 86-98
    CrossRef

  55. 55

    William D. Gaillard, Catherine Chiron, J. Helen Cross, A. Simon Harvey, Ruben Kuzniecky, Lucie Hertz-Pannier, L. Gilbert Vezina. (2009) Guidelines for imaging infants and children with recent-onset epilepsy. Epilepsia 50:9, 2147-2153
    CrossRef

  56. 56

    Gail S Bell, Athanasios Gaitatzis, Catherine L Bell, Anthony L Johnson, Josemir W Sander. (2009) Suicide in people with epilepsy: How great is the risk?. Epilepsia 50:8, 1933-1942
    CrossRef

  57. 57

    Cassandra Kazl, L. Tracy Foote, Min-Jung Kim, Sookyong Koh. (2009) Early-life experience alters response of developing brain to seizures. Brain Research 1285, 174-181
    CrossRef

  58. 58

    T. J. Achterberg, H. Wind, A. G. E. M. Boer, M. H. W. Frings-Dresen. (2009) Factors that Promote or Hinder Young Disabled People in Work Participation: A Systematic Review. Journal of Occupational Rehabilitation 19:2, 129-141
    CrossRef

  59. 59

    Sherifa A. Hamed. (2009) The Aspects and Mechanisms of Cognitive Alterations in Epilepsy: The Role of Antiepileptic Medications. CNS Neuroscience & Therapeutics 15:2, 134-156
    CrossRef

  60. 60

    Matti Sillanpää, J. Helen Cross. (2009) The psychosocial impact of epilepsy in childhood. Epilepsy & Behavior 15:2, S5-S10
    CrossRef

  61. 61

    Havisha B. Karnam, Jun-Li Zhou, Li-Tung Huang, Qian Zhao, Tatiana Shatskikh, Gregory L. Holmes. (2009) Early life seizures cause long-standing impairment of the hippocampal map. Experimental Neurology 217:2, 378-387
    CrossRef

  62. 62

    Willem F.M. Arts, Ada T. Geerts. (2009) When to start drug treatment for childhood epilepsy: The clinical–epidemiological evidence. European Journal of Paediatric Neurology 13:2, 93-101
    CrossRef

  63. 63

    Eeva Löfgren, Anneli Pouta, Lennart von Wendt, Juha Tapanainen, Jouko I.T. Isojärvi, Marjo-Riitta Järvelin. (2009) Epilepsy in the northern Finland birth cohort 1966 with special reference to fertility. Epilepsy & Behavior 14:1, 102-107
    CrossRef

  64. 64

    P. Vincent, C. Mulle. (2009) Kainate receptors in epilepsy and excitotoxicity. Neuroscience 158:1, 309-323
    CrossRef

  65. 65

    Robert S. Fisher, Ilo Leppik. (2008) Debate: When does a seizure imply epilepsy?. Epilepsia 49, 7-12
    CrossRef

  66. 66

    Bruce P. Hermann, Jana E. Jones, Raj Sheth, Monica Koehn, Tara Becker, Jason Fine, Chase A. Allen, Michael Seidenberg. (2008) Growing up with epilepsy: A two-year investigation of cognitive development in children with new onset epilepsy. Epilepsia 49:11, 1847-1858
    CrossRef

  67. 67

    D. Schiff. (2008) Mortality Following Febrile Seizures. AAP Grand Rounds 20:5, 53-54
    CrossRef

  68. 68

    Cristina Go, O. Carter Snead. (2008) Pharmacologically intractable epilepsy in children: diagnosis and preoperative evaluation. Neurosurgical FOCUS 25:3, E2
    CrossRef

  69. 69

    Mogens Vestergaard, Marianne Giørtz Pedersen, John R Østergaard, Carsten Bøcker Pedersen, Jørn Olsen, Jakob Christensen. (2008) Death in children with febrile seizures: a population-based cohort study. The Lancet 372:9637, 457-463
    CrossRef

  70. 70

    Christian R. Marshall, Edwin J. Young, Ariel M. Pani, Mary-Louise Freckmann, Yves Lacassie, Cédric Howald, Kristi K. Fitzgerald, Maarit Peippo, Colleen A. Morris, Kate Shane, Manuela Priolo, Masafumi Morimoto, Ikuko Kondo, Esra Manguoglu, Sibel Berker-Karauzum, Patrick Edery, Holly H. Hobart, Carolyn B. Mervis, Orsetta Zuffardi, Alexandre Reymond, Paige Kaplan, May Tassabehji, Ronald G. Gregg, Stephen W. Scherer, Lucy R. Osborne. (2008) Infantile Spasms Is Associated with Deletion of the MAGI2 Gene on Chromosome 7q11.23-q21.11. The American Journal of Human Genetics 83:1, 106-111
    CrossRef

  71. 71

    M. Sillanpaa, D. Schmidt. (2008) Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsy. Brain 132:4, 989-998
    CrossRef

  72. 72

    P. Ryvlin, A. Montavont. (2008) La chirurgie de l’épilepsie réduit-elle la surmortalité des épilepsies partielles pharmacorésistantes ?. Neurochirurgie 54:3, 282-286
    CrossRef

  73. 73

    Bruce Hermann, Michael Seidenberg, Jana Jones. (2008) The neurobehavioural comorbidities of epilepsy: can a natural history be developed?. The Lancet Neurology 7:2, 151-160
    CrossRef

  74. 74

    Knut Stavem, Helge Bjørnæs, Iver A. Langmoen. (2008) LONG-TERM SEIZURES AND QUALITY OF LIFE AFTER EPILEPSY SURGERY COMPARED WITH MATCHED CONTROLS. Neurosurgery 62:2, 326-335
    CrossRef

  75. 75

    T. Matthews, N. Weston, H. Baxter, D. Felce, M. Kerr. (2008) A general practice-based prevalence study of epilepsy among adults with intellectual disabilities and of its association with psychiatric disorder, behaviour disturbance and carer stress. Journal of Intellectual Disability Research 52:2, 163-173
    CrossRef

  76. 76

    Anannit Visudtibhan, Atthaporn Boongird, Chaiyos Khongkhatithum, Lunliya Thampratankul, The Ramathibodi Epilepsy Surgery Group. (2008) Epilepsy Surgery in Children in Thailand: Preliminary Result from a Referral Center. Epilepsy & Seizure 1:1, 47-56
    CrossRef

  77. 77

    Andres M. Kanner. (2008) Psychiatric Comorbidity in Children with Epilepsy … or Is It: Epilepsy Comorbidity in Children with Psychiatric Disorders?. Epilepsy Currents 8:1, 10-12
    CrossRef

  78. 78

    Edgar A. Samaniego, Raj D. Sheth. (2007) Bone Consequences of Epilepsy and Antiepileptic Medications. Seminars in Pediatric Neurology 14:4, 196-200
    CrossRef

  79. 79

    Jay A. Salpekar, David W. Dunn. (2007) Psychiatric and Psychosocial Consequences of Pediatric Epilepsy. Seminars in Pediatric Neurology 14:4, 181-188
    CrossRef

  80. 80

    Bruce P. Hermann, Jana Jones, Raj Sheth, Michael Seidenberg. (2007) Cognitive and Magnetic Resonance Volumetric Abnormalities in New-Onset Pediatric Epilepsy. Seminars in Pediatric Neurology 14:4, 173-180
    CrossRef

  81. 81

    M. Sadegh, J. Mirnajafi-Zadeh, M. Javan, Y. Fathollahi, M. Mohammad-Zadeh, A. Jahanshahi, S.M. Noorbakhsh. (2007) The role of galanin receptors in anticonvulsant effects of low-frequency stimulation in perforant path–kindled rats. Neuroscience 150:2, 396-403
    CrossRef

  82. 82

    Ann Johnston, Phil Smith. (2007) Sudden unexpected death in epilepsy. Expert Review of Neurotherapeutics 7:12, 1751-1761
    CrossRef

  83. 83

    SIGITA PLIOPLYS, DAVID W. DUNN, ROCHELLE CAPLAN. (2007) 10-Year Research Update Review: Psychiatric Problems in Children With Epilepsy. Journal of the American Academy of Child & Adolescent Psychiatry 46:11, 1389-1402
    CrossRef

  84. 84

    Anna L. Luciano, Simon D. Shorvon. (2007) Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Annals of Neurology 62:4, 375-381
    CrossRef

  85. 85

    Andrew C.F. Hui, Adrian Wong, H.C. Wong, B.L. Man, K.M. Au-Yeung, K.S. Wong. (2007) Refractory epilepsy in a Chinese population. Clinical Neurology and Neurosurgery 109:8, 672-675
    CrossRef

  86. 86

    Hans Stroink, Ada T. Geerts, Cees A. van Donselaar, A. C. Boudewijn Peters, Oebele F. Brouwer, Els A. Peeters, Willem F. Arts. (2007) Status Epilepticus in Children with Epilepsy: Dutch Study of Epilepsy in Childhood. Epilepsia 48:9, 1708-1715
    CrossRef

  87. 87

    John W. Swann, John T. Le, Trang T. Lam, James Owens, Adam T. Mayer. (2007) The impact of chronic network hyperexcitability on developing glutamatergic synapses. European Journal of Neuroscience 26:4, 975-991
    CrossRef

  88. 88

    Maromi Nei, Ritu Bagla. (2007) Seizure-related injury and death. Current Neurology and Neuroscience Reports 7:4, 335-341
    CrossRef

  89. 89

    Elena Harlan Drewel, Rochelle Caplan. (2007) Social difficulties in children with epilepsy: review and treatment recommendations. Expert Review of Neurotherapeutics 7:7, 865-873
    CrossRef

  90. 90

    Peter Camfield, Carol Camfield. (2007) Long-term Prognosis for Symptomatic (Secondarily) Generalized Epilepsies: A Population-based Study. Epilepsia 48:6, 1128-1132
    CrossRef

  91. 91

    Sanjeev V Kothare, Joseph Kaleyias. (2007) The adverse effects of antiepileptic drugs in children. Expert Opinion on Drug Safety 6:3, 251-265
    CrossRef

  92. 92

    Lina Nashef, Neeti Hindocha, Andrew Makoff. (2007) Risk Factors in Sudden Death in Epilepsy (SUDEP): The Quest for Mechanisms. Epilepsia 48:5, 859-871
    CrossRef

  93. 93

    M. Falip, L. Artazcoz, P. de la Peña, A. Pérez-Sempere, M. Codina. (2007) Clinical characteristics associated with psychosocial functioning among patients with uncomplicated epilepsy in Spain. Seizure 16:3, 195-203
    CrossRef

  94. 94

    Lena K.A. Räty, Bodil M. Wilde Larsson. (2007) Quality of life in young adults with uncomplicated epilepsy. Epilepsy & Behavior 10:1, 142-147
    CrossRef

  95. 95

    Sookyong Koh, Rhamy Magid, Hyokwon Chung, Christy D. Stine, Dawn N. Wilson. (2007) Depressive behavior and selective downregulation of serotonin receptor expression after early-life seizures: Reversal by environmental enrichment. Epilepsy & Behavior 10:1, 26-31
    CrossRef

  96. 96

    Bruce Hermann, Michael Seidenberg. (2007) Epilepsy and Cognition. Epilepsy Currents 7:1, 1-6
    CrossRef

  97. 97

    Pat L. Sample, Pamela L. Ferguson, Janelle L. Wagner, E. Elisabeth Pickelsimer, Anbesaw W. Selassie. (2006) Experiences of persons with epilepsy and their families as they look for medical and community care: A focus group study from South Carolina. Epilepsy & Behavior 9:4, 649-662
    CrossRef

  98. 98

    Yehezkel Ben-Ari, Gregory L Holmes. (2006) Effects of seizures on developmental processes in the immature brain. The Lancet Neurology 5:12, 1055-1063
    CrossRef

  99. 99

    John W. Miller. (2006) Long-Term Outcomes of Childhood Epilepsy: "The Truth Is Rarely Pure and Never Simple" 1. Epilepsy Currents 6:6, 181-183
    CrossRef

  100. 100

    Warren T. Blume. (2006) The Progression of Epilepsy. Epilepsia 47:s1, 71-78
    CrossRef

  101. 101

    Mohammad Reza Mohammadi, Ahmad Ghanizadeh, Haratoun Davidian, Mohammad Mohammadi, Maryam Norouzian. (2006) Prevalence of epilepsy and comorbidity of psychiatric disorders in Iran. Seizure 15:7, 476-482
    CrossRef

  102. 102

    John M. Pellock, Edward Faught, Ilo E. Leppik, Shlomo Shinnar, Mary L. Zupanc. (2006) Felbamate: Consensus of current clinical experience. Epilepsy Research 71:2-3, 89-101
    CrossRef

  103. 103

    C. Rocco, D. Battaglia, D. Pietrini, M. Piastra, L. Massimi. (2006) Hemimegalencephaly: clinical implications and surgical treatment. Child's Nervous System 22:8, 852-866
    CrossRef

  104. 104

    Katherine F.Y. Chan, W. McIntyre Burnham, Zhengping Jia, Miguel A. Cortez, O. Carter Snead. (2006) GABAB receptor antagonism abolishes the learning impairments in rats with chronic atypical absence seizures. European Journal of Pharmacology 541:1-2, 64-72
    CrossRef

  105. 105

    Dominik Zumsteg, Andres M. Lozano, Richard A. Wennberg. (2006) Depth electrode recorded cerebral responses with deep brain stimulation of the anterior thalamus for epilepsy. Clinical Neurophysiology 117:7, 1602-1609
    CrossRef

  106. 106

    Rianne P. Reijs, Saskia G.M. van Mil, Mariette H.J.A. van Hall, Johan B.A.M. Arends, Jacobiene W. Weber, Wil O. Renier, Albert P. Aldenkamp. (2006) Cryptogenic localization-related epilepsy with childhood onset: The problem of definition and prognosis. Epilepsy & Behavior 8:4, 693-702
    CrossRef

  107. 107

    M. Sillanpää, D. Schmidt. (2006) Prognosis of seizure recurrence after stopping antiepileptic drugs in seizure-free patients: A long-term population-based study of childhood-onset epilepsy. Epilepsy & Behavior 8:4, 713-719
    CrossRef

  108. 108

    Gregory L. Holmes, Pierre-Pascal Lenck-Santini. (2006) Role of interictal epileptiform abnormalities in cognitive impairment. Epilepsy & Behavior 8:3, 504-515
    CrossRef

  109. 109

    Elizabeth J. Donner, O. Carter Snead. (2006) New generation anticonvulsants for the treatment of epilepsy in children. NeuroRX 3:2, 170-180
    CrossRef

  110. 110

    R. Mohanraj, M. J. Brodie. (2006) Diagnosing refractory epilepsy: response to sequential treatment schedules. European Journal of Neurology 13:3, 277-282
    CrossRef

  111. 111

    H. Stefan, F. H. Lopes da Silva, W. Loscher, D. Schmidt, E. Perucca, M. J. Brodie, P. A. J. M. Boon, W. H. Theodore, S. L. Moshe. (2006) Epileptogenesis and rational therapeutic strategies. Acta Neurologica Scandinavica 113:3, 139-155
    CrossRef

  112. 112

    Elizabeth J. Donner, O. Carter Snead. (2006) New generation anticonvulsants for the treatment of epilepsy in children. Neurotherapeutics 3:2, 170
    CrossRef

  113. 113

    Michael R. Sperling, Adam Harris, Maromi Nei, Joyce D. Liporace, Michael J. O'Connor. (2005) Mortality after Epilepsy Surgery. Epilepsia 46:s11, 49-53
    CrossRef

  114. 114

    Lars Forsgren, W. Allen Hauser, Elias Olafsson, J. W. A. S. Sander, Matti Sillanpaa, Torbjorn Tomson. (2005) Mortality of Epilepsy in Developed Countries: A Review. Epilepsia 46:s11, 18-27
    CrossRef

  115. 115

    P. Wolf. (2005) Determinants of outcome in childhood epilepsy. Acta Neurologica Scandinavica 112:s182, 5-8
    CrossRef

  116. 116

    J. T. Butler. (2005) The role of epilepsy surgery in southern Africa. Acta Neurologica Scandinavica 112:s181, 12-16
    CrossRef

  117. 117

    Shung-Lon Lai, Min-Tao Hsu, Shun-Sheng Chen. (2005) The impact of SARS on epilepsy: The experience of drug withdrawal in epileptic patients. Seizure 14:8, 557-561
    CrossRef

  118. 118

    M. J. Brodie. (2005) Diagnosing and predicting refractory epilepsy. Acta Neurologica Scandinavica 112:s181, 36-39
    CrossRef

  119. 119

    Pierre Jallon, Patrick Latour. (2005) Epidemiology of Idiopathic Generalized Epilepsies. Epilepsia 46:s9, 10-14
    CrossRef

  120. 120

    Anne T Berg, Susan N Smith, Daniel Frobish, Susan R Levy, Francine M Testa, Barbara Beckerman, Shlomo Shinnar. (2005) Special education needs of children with newly diagnosed epilepsy. Developmental Medicine & Child Neurology 47:11, 749-753
    CrossRef

  121. 121

    S. Arroyo, W. E. Dodson, M. D. Privitera, T. A. Glauser, D. K. Naritoku, D. J. Dlugos, S. Wang, S. K. Schwabe, R. E. Twyman, . (2005) Randomized dose-controlled study of topiramate as first-line therapy in epilepsy. Acta Neurologica Scandinavica 112:4, 214-222
    CrossRef

  122. 122

    Miranda Geelhoed, Anne Olde Boerrigter, Peter Camfield, Ada T. Geerts, Willem Arts, Bruce Smith, Carol Camfield. (2005) The Accuracy of Outcome Prediction Models for Childhood-onset Epilepsy. Epilepsia 46:9, 1526-1532
    CrossRef

  123. 123

    Rajiv Mohanraj, Martin J Brodie. (2005) Outcomes in newly diagnosed localization-related epilepsies. Seizure 14:5, 318-323
    CrossRef

  124. 124

    Frank G Gilliam. (2005) Diagnosis and treatment of mood disorders in persons with epilepsy. Current Opinion in Neurology 18:2, 129-133
    CrossRef

  125. 125

    Peter Camfield, Carol Camfield. (2005) Sudden Unexpected Death in People with Epilepsy: A Pediatric Perspective. Seminars in Pediatric Neurology 12:1, 10-14
    CrossRef

  126. 126

    F. Unglaub, C. Prueter, F. Block, N. Pallua. (2005) Groflchige Verbrhung nach einem epileptischen Anfall whrend des Duschens. Der Nervenarzt 76:2, 209-211
    CrossRef

  127. 127

    Hoon Chul Kang, Yong Joo Kim, Dong Wook Kim, Heung Dong Kim. (2005) Efficacy and Safety of the Ketogenic Diet for Intractable Childhood Epilepsy: Korean Multicentric Experience. Epilepsia 46:2, 272-279
    CrossRef

  128. 128

    Martin J. Brodie. (2005) Medical therapy of epilepsy: When to initiate treatment and when to combine?. Journal of Neurology 252:2, 125-130
    CrossRef

  129. 129

    Matti Sillanpää. (2004) Learning disability: occurrence and long-term consequences in childhood-onset epilepsy. Epilepsy & Behavior 5:6, 937-944
    CrossRef

  130. 130

    Katherine F.Y. Chan, Zhengping Jia, Patricia A. Murphy, W. McIntyre Burnham, Miguel A. Cortez, O. Carter Snead. (2004) Learning and memory impairment in rats with chronic atypical absence seizures. Experimental Neurology 190:2, 328-336
    CrossRef

  131. 131

    Philip S. Fastenau, Jianzhao Shen, David W. Dunn, Susan M. Perkins, Bruce P. Hermann, Joan K. Austin. (2004) Neuropsychological Predictors of Academic Underachievement in Pediatric Epilepsy: Moderating Roles of Demographic, Seizure, and Psychosocial Variables. Epilepsia 45:10, 1261-1272
    CrossRef

  132. 132

    John M. Pellock. (2004) Defining the problem: psychiatric and behavioral comorbidity in children and adolescents with epilepsy. Epilepsy & Behavior 5, 3-9
    CrossRef

  133. 133

    Hoon Chul Kang, Da Eun Chung, Dong Wook Kim, Heung Dong Kim. (2004) Early- and Late-onset Complications of the Ketogenic Diet for Intractable Epilepsy. Epilepsia 45:9, 1116-1123
    CrossRef

  134. 134

    Grant Butterbaugh, Piotr Olejniczak, Betsy Roques, Richard Costa, Marcy Rose, Bruce Fisch, Michael Carey, Jessica Thomson, John Skinner. (2004) Lateralization of Temporal Lobe Epilepsy and Learning Disabilities, as Defined by Disability-related Civil Rights Law. Epilepsia 45:8, 963-970
    CrossRef

  135. 135

    Matti Sillanpaa, Leena Haataja, Shlomo Shinnar. (2004) Perceived Impact of Childhood-onset Epilepsy on Quality of Life as an Adult. Epilepsia 45:8, 971-977
    CrossRef

  136. 136

    Gholam K. Motamedi, Kimford J. Meador. (2004) Antiepileptic drugs and memory. Epilepsy & Behavior 5:4, 435-439
    CrossRef

  137. 137

    Sookyong Koh, Felicia D. Tibayan, Joelle N. Simpson, Frances E. Jensen. (2004) NBQX or Topiramate Treatment after Perinatal Hypoxia-induced Seizures Prevents Later Increases in Seizure-induced Neuronal Injury. Epilepsia 45:6, 569-575
    CrossRef

  138. 138

    Torbjörn Tomson, Ettore Beghi, Anders Sundqvist, Svein I Johannessen. (2004) Medical risks in epilepsy: a review with focus on physical injuries, mortality, traffic accidents and their prevention. Epilepsy Research 60:1, 1-16
    CrossRef

  139. 139

    Gregory L. Holmes. (2004) Effects of early seizures on later behavior and epileptogenicity. Mental Retardation and Developmental Disabilities Research Reviews 10:2, 101-105
    CrossRef

  140. 140

    Raj D. Sheth. (2004) Bone health in pediatric epilepsy. Epilepsy & Behavior 5, 30-35
    CrossRef

  141. 141

    Luigi M Specchio, Ettore Beghi. (2004) Should Antiepileptic Drugs Be Withdrawn in Seizure-Free Patients?. CNS Drugs 18:4, 201-212
    CrossRef

  142. 142

    Tamara Bushnik, Jeffrey Englander, Thao Duong. (2004) Medical and Social Issues Related to Posttraumatic Seizures in Persons With Traumatic Brain Injury. Journal of Head Trauma Rehabilitation 19:4, 296-304
    CrossRef

  143. 143

    LINDA J STEPHEN, JAN MAXWELL, MARTIN J BRODIE. (2003) Outcomes from a nurse-led clinic for adolescents with epilepsy. Seizure 12:8, 539-544
    CrossRef

  144. 144

    Michael Rutter, Avshalom Caspi, Terrie E. Moffitt. (2003) Using sex differences in psychopathology to study causal mechanisms: unifying issues and research strategies. Journal of Child Psychology and Psychiatry 44:8, 1092-1115
    CrossRef

  145. 145

    Gholam Motamedi, Kimford Meador. (2003) Epilepsy and cognition. Epilepsy & Behavior 4, 25-38
    CrossRef

  146. 146

    P Ryvlin, P Kahane. (2003) Does epilepsy surgery lower the mortality of drug-resistant epilepsy?. Epilepsy Research 56:2-3, 105-120
    CrossRef

  147. 147

    (2003) Clinical Neuropsychology: Cognitive Function in Epilepsy. Epilepsia 44, 29-30
    CrossRef

  148. 148

    Frank Gilliam. (2003) The impact of epilepsy on subjective health status. Current Neurology and Neuroscience Reports 3:4, 357-362
    CrossRef

  149. 149

    Christian E. Elger. (2003) Pharmacoresistance: Modern Concept and Basic Data Derived from Human Brain Tissue. Epilepsia 44, 9-15
    CrossRef

  150. 150

    Andres M. Kanner. (2003) The Complex Epilepsy Patient: Intricacies of Assessment and Treatment. Epilepsia 44, 3-8
    CrossRef

  151. 151

    LENA K.A. RÄTY, BODIL WILDE-LARSSON, BIRGITTA A. SÖDERFELDT. (2003) Seizures and therapy in adolescents with uncomplicated epilepsy. Seizure 12:4, 229-236
    CrossRef

  152. 152

    Gregory L Krauss, Eva K Ritzl. (2003) Identifying and treating clinical subgroups of patients with epilepsy: a case review. Medical Clinics of North America 87:3, 725-746
    CrossRef

  153. 153

    Jane Williams. (2003) Learning and behavior in children with epilepsy. Epilepsy & Behavior 4:2, 107-111
    CrossRef

  154. 154

    A.P ALDENKAMP, C.A VAN DONSELAAR, H FLAMMAN, D.L.W LAFARRE. (2003) Psychosocial reactions to the epilepsy in an unselected group of patients with epilepsy under treatment in general hospitals. Seizure 12:2, 101-106
    CrossRef

  155. 155

    H. Lindsten, H. Stenlund, L. Forsgren. (2003) Leisure time and social activity after a newly diagnosed unprovoked epileptic seizure in adult age. A population-based case-referent study. Acta Neurologica Scandinavica 107:2, 125-133
    CrossRef

  156. 156

    A. A. Cohen-Gadol, J. W. Britton, N. M. Wetjen, W. R. Marsh, F. B. Meyer, C. Raffel. (2003) Neurostimulation Therapy for Epilepsy: Current Modalities and Future Directions. Mayo Clinic Proceedings 78:2, 238-248
    CrossRef

  157. 157

    W. Allen Hauser. 2003. Epilepsy, Prognosis. , 224-229.
    CrossRef

  158. 158

    J. W. Britton. (2002) Antiepileptic Drug Withdrawal: Literature Review. Mayo Clinic Proceedings 77:12, 1378-1388
    CrossRef

  159. 159

    Irene A. W. Kotsopoulos, Tiny Van Merode, Fons G. H. Kessels, Marc C. T. F. M. De Krom, J. André Knottnerus. (2002) Systematic Review and Meta-analysis of Incidence Studies of Epilepsy and Unprovoked Seizures. Epilepsia 43:11, 1402-1409
    CrossRef

  160. 160

    József Janszky, Anna Szücs. (2002) Death in children with epilepsy. The Lancet 360:9346, 1698
    CrossRef

  161. 161

    Raj D Sheth. (2002) Epilepsy surgery. Neurologic Clinics 20:4, 1195-1215
    CrossRef

  162. 162

    Collin A Hovinga. (2002) Novel anticonvulsant medications in development. Expert Opinion on Investigational Drugs 11:10, 1387-1406
    CrossRef

  163. 163

    Hans Lindsten, Hans Stenlund, Curt Edlund, Lars Forsgren. (2002) Socioeconomic Prognosis after a Newly Diagnosed Unprovoked Epileptic Seizure in Adults: A Population-based Case-Control Study. Epilepsia 43:10, 1239-1250
    CrossRef

  164. 164

    Matti Sillanp, Shlomo Shinnar. (2002) Status epilepticus in a population-based cohort with childhood-onset epilepsy in Finland. Annals of Neurology 52:3, 303-310
    CrossRef

  165. 165

    Andres M. Kanner, Susan Palac. (2002) Neuropsychiatric complications of epilepsy. Current Neurology and Neuroscience Reports 2:4, 365-372
    CrossRef

  166. 166

    A Gaitatzis, B Purcell, K Carroll, J.W.A.S Sander, A Majeed. (2002) Differences in the use of health services among people with and without epilepsy in the United Kingdom: socio-economic and disease-specific determinants. Epilepsy Research 50:3, 233-241
    CrossRef

  167. 167

    Carol S Camfield, Peter R Camfield, Paul J Veugelers. (2002) Death in children with epilepsy: a population-based study. The Lancet 359:9321, 1891-1895
    CrossRef

  168. 168

    Patrick Kwan, Martin J Brodie. (2002) Refractory epilepsy: a progressive, intractable but preventable condition?. Seizure 11:2, 77-84
    CrossRef

  169. 169

    Frank M.C. Besag. (2002) Childhood epilepsy in relation to mental handicap and behavioural disorders. Journal of Child Psychology and Psychiatry 43:1, 103-131
    CrossRef

  170. 170

    Anne T. Berg, Shlomo Shinnar, Susan R. Levy, Francine M. Testa, Susan Smith-Rapaport, Barbara Beckerman, Nader Ebrahimi. (2001) Two-Year Remission and Subsequent Relapse in Children with Newly Diagnosed Epilepsy. Epilepsia 42:12, 1553-1562
    CrossRef

  171. 171

    K. J. Oostrom, A. Schouten, C. L. J. J. Kruitwagen, A. C. B. Peters, . (2001) Parents' Perceptions of Adversity Introduced by Upheaval and Uncertainty at the Onset of Childhood Epilepsy. Epilepsia 42:11, 1452-1460
    CrossRef

  172. 172

    Collin A. Hovinga. (2001) Levetiracetam: A Novel Antiepileptic Drug. Pharmacotherapy 21:11, 1375-1388
    CrossRef

  173. 173

    Hans Lindsten, Hans Stenlund, Lars Forsgren. (2001) Remission of Seizures in a Population-Based Adult Cohort with a Newly Diagnosed Unprovoked Epileptic Seizure. Epilepsia 42:8, 1025-1030
    CrossRef

  174. 174

    Kimford J. Meador, Frank G. Gilliam, Andres M. Kanner, John M. Pellock. (2001) Cognitive and Behavioral Effects of Antiepileptic Drugs. Epilepsy & Behavior 2:4, SS1-SS17
    CrossRef

  175. 175

    A Schouten, K Oostrom, A Jennekens-Schinkel, ACB Peters. (2001) ‘School career of children is at risk before diagnosis of epilepsy only’. Developmental Medicine & Child Neurology 43:8, 575a-576
    CrossRef

  176. 176

    Bridget MacDonald. (2001) The prognosis of epilepsy. Seizure 10:5, 347-358
    CrossRef

  177. 177

    Jane Williams, Tonya Phillips, May L. Griebel, Gregory B. Sharp, Bernadette Lange, Terence Edgar, Pippa Simpson. (2001) Factors Associated with Academic Achievement in Children with Controlled Epilepsy. Epilepsy & Behavior 2:3, 217-223
    CrossRef

  178. 178

    Christine O'Dell, Shlomo Shinnar. (2001) Initiation and discontinuation of antiepileptic drugs. Neurologic Clinics 19:2, 289-311
    CrossRef

  179. 179

    Shlomo Shinnar, Anne T. Berg, David M. Treiman, W. Allen Hauser, Dale C. Hesdorffer, J. Chris Sackellares, Ilo Leppik, Matti Sillanpaa, Kenneth W. Sommerville. (2001) Status Epilepticus and Tiagabine Therapy: Review of Safety Data and Epidemiologic Comparisons. Epilepsia 42:3, 372-379
    CrossRef

  180. 180

    Samden D. Lhatoo, Anthony L. Johnson, David M. Goodridge, Bridget K. MacDonald, Josemir W. A. S. Sander, Simon D. Shorvon. (2001) Mortality in epilepsy in the first 11 to 14 years after diagnosis: Multivariate analysis of a long-term, prospective, population-based cohort. Annals of Neurology 49:3, 336-344
    CrossRef

  181. 181

    Anneli Kolk, Anneli Beilmann, Tiiu Tomberg, Aita Napa, Tiina Talvik. (2001) Neurocognitive development of children with congenital unilateral brain lesion and epilepsy. Brain and Development 23:2, 88-96
    CrossRef

  182. 182

    Andres M. Kanner. (2001) The Behavioral Aspects of Epilepsy: An Overview of Controversial Issues. Epilepsy & Behavior 2:1, 8-12
    CrossRef

  183. 183

    B. Vissel, G.A. Royle, B.R. Christie, H.H. Schiffer, A. Ghetti, T. Tritto, I. Perez-Otano, R.A. Radcliffe, J. Seamans, T. Sejnowski, J.M. Wehner, A.C. Collins, S. O'Gorman, S.F. Heinemann. (2001) The Role of RNA Editing of Kainate Receptors in Synaptic Plasticity and Seizures. Neuron 29:1, 217-227
    CrossRef

  184. 184

    Patrick Kwan, Martin J Brodie. (2001) Neuropsychological effects of epilepsy and antiepileptic drugs. The Lancet 357:9251, 216-222
    CrossRef

  185. 185

    Anne T. Berg, Shlomo Shinnar, Susan R. Levy, Francine M. Testa, Susan Smith-Rapaport, Barbara Beckerman, Nader Ebrahimi. (2001) Defining early seizure outcomes in pediatric epilepsy: the good, the bad and the in-between. Epilepsy Research 43:1, 75-84
    CrossRef

  186. 186

    Mervyn J. Eadie. (2001) Can Anticonvulsant Drug Therapy ???Cure??? Epilepsy?. CNS Drugs 15:9, 679-690
    CrossRef

  187. 187

    Hans Lindsten, Lennart Nystrom, Lars Forsgren. (2000) Mortality Risk in an Adult Cohort with a Newly Diagnosed Unprovoked Epileptic Seizure: A Population-Based Study. Epilepsia 41:11, 1469-1473
    CrossRef

  188. 188

    K. Patja, M. Iivanainen, H. Vesala, H. Oksanen, I. Ruoppila. (2000) Life expectancy of people with intellectual disability: a 35-year follow-up study. Journal of Intellectual Disability Research 44:5, 591-599
    CrossRef

  189. 189

    Anne T. Berg, Shlorao Shinnar, Susan R. Levy, Francine M. Testa, Susan Smith-Rapaport, Barbara Beckerman. (2000) How Well Can Epilepsy Syndromes Be Identified at Diagnosis? A Reassessment 2 Years After Initial Diagnosis. Epilepsia 41:10, 1269-1275
    CrossRef

  190. 190

    Patrick Kwan, Martin J Brodie. (2000) Epilepsy after the first drug fails: substitution or add-on?. Seizure 9:7, 464-468
    CrossRef

  191. 191

    Eila M. Airaksinen, Riitta Matilainen, Tarja Mononen, Kirsi Mustonen, Juhani Partanen, Veikko Jokela, Pirjo Halonen. (2000) A Population-Based Study on Epilepsy in Mentally Retarded Children. Epilepsia 41:9, 1214-1220
    CrossRef

  192. 192

    Kosaburo Aso, Kazuyoshi Watanabe. (2000) Limitations in the Medical Treatment of Cryptogenic or Symptomatic Localization-Related Epilepsies of Childhood Onset. Epilepsia 41:s9, 18-20
    CrossRef

  193. 193

    Shlomo Shinnar, Anne T. Berg, Christine O'Dell, David Newstein, Solomon L. Moshe, W. Allen Hauser. (2000) Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure. Annals of Neurology 48:2, 140-147
    CrossRef

  194. 194

    Robert S Fisher, Barbara G Vickrey, Patricia Gibson, Bruce Hermann, Patricia Penovich, Ann Scherer, Steven Walker. (2000) The impact of epilepsy from the patient’s perspective I. Descriptions and subjective perceptions. Epilepsy Research 41:1, 39-51
    CrossRef

  195. 195

    Emilio Perucca, Ettore Beghi, Olivier Dulac, Simon Shorvon, Torbjörn Tomson. (2000) Assessing risk to benefit ratio in antiepileptic drug therapy. Epilepsy Research 41:2, 107-139
    CrossRef

  196. 196

    P. E. Waaler, B. H. Blom, H. Skeidsvoll, A. Mykletum. (2000) Prevalence, Classification, and Severity of Epilepsy in Children in Western Norway. Epilepsia 41:7, 802-810
    CrossRef

  197. 197

    H Wakamoto. (2000) Long-term medical, educational, and social prognoses of childhood-onset epilepsy: a population-based study in a rural district of Japan. Brain and Development 22:4, 246-255
    CrossRef

  198. 198

    Joan K. Austin, David W. Dunn, Gertrude A. Huster. (2000) Childhood Epilepsy and Asthma: Changes in Behavior Problems Related to Gender and Change in Condition Severity. Epilepsia 41:5, 615-623
    CrossRef

  199. 199

    Steven C. Schachter. (2000) Epilepsy: Quality of Life and Cost of Care. Epilepsy & Behavior 1:2, 120-127
    CrossRef

  200. 200

    Kwan, Patrick, Brodie, Martin J., . (2000) Early Identification of Refractory Epilepsy. New England Journal of Medicine 342:5, 314-319
    Full Text

  201. 201

    Knut Stavem, Jon Havard Loge, Stein Kaasa. (2000) Health Status of People with Epilepsy Compared with a General Reference Population. Epilepsia 41:1, 85-90
    CrossRef

  202. 202

    Shlomo Shinnar, Christine O'Dell, Anne T. Berg. (1999) Distribution of Epilepsy Syndromes in a Cohort of Children Prospectively Monitored from the Time of Their First Unprovoked Seizure. Epilepsia 40:10, 1378-1383
    CrossRef

  203. 203

    Jeffrey R. Buchhalter. (1999) Complex partial seizures in children. Current Treatment Options in Neurology 1:4, 339-351
    CrossRef

  204. 204

       . (1999) Late gevolgen van convulsies. Medisch-Farmaceutische Mededelingen 37:8, 173-173
    CrossRef

  205. 205

    Michael R. Sperling, Harold Feldman, Judith Kinman, Joyce D. Liporace, Michael J. O'Connor. (1999) Seizure control and mortality in epilepsy. Annals of Neurology 46:1, 45-50
    CrossRef

  206. 206

    Joan K Austin, Thomas J Huberty, Gertrude A Huster, David W Dunn. (1999) Does academic achievement in children with epilepsy change over time?. Developmental Medicine & Child Neurology 41:7, 473-479
    CrossRef

  207. 207

    Thomas P. Sutula, Bruce Hermann. (1999) Progression in mesial temporal lobe epilepsy. Annals of Neurology 45:5, 553-556
    CrossRef

  208. 208

    Anne T. Berg, Shlomo Shinnar, Susan R. Levy, Francine M. Testa. (1999) Newly Diagnosed Epilepsy in Children: Presentation at Diagnosis. Epilepsia 40:4, 445-452
    CrossRef

  209. 209

    Vining, Eileen P.G., . (1998) Gaining a Perspective on Childhood Seizures. New England Journal of Medicine 338:26, 1916-1918
    Full Text